Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Production & Manufacturing
OTC
Return to: PBR Home | Production & Manufacturing | OTC

OTC

Actavis seeks FDA approval to market generic ulcerative colitis drug Uceris By PBR Staff Writer
Irish specialty pharmaceutical firm Actavis has submitted an abbreviated new drug application (ANDA) to the US Food and Drug Administration (FDA) seeking approval to market Budesonide Extended-release Tablets, 9mg.
Production & Manufacturing > OTC > News
India’s Elder Pharma expands its Solo range of OTC products By PBR Staff Writer
India-based Elder Pharmaceuticals has launched Solo range of inhalers for nasal congestion, which comprises of Solo Rub, a pain balm, Solo Cough Drops and Solo lozenges for throat soothening.
Production & Manufacturing > OTC > News Researchers review use of aspirin for cardiovascular disease prevention By PBR Staff Writer
Researchers at Baylor College of Medicine and the Michael E. DeBakey Veterans Affairs Medical Center have evaluated the use of aspirin, an over-the-counter drug, for primary cardiovascular disease prevention.
Production & Manufacturing > OTC > News
See more OTC news

Latest OTC News and Insight

View all OTC news or find news targeted to your interests
Targeted Medical enters into distribution agreement with J-Network in Japan
By PBR Staff Writer
Targeted Medical Pharma (TRGM) has entered into a new product distribution agreement with J-Network, which specializes in distributing cosmetic and healthcare goods exclusively to Japan.
Production & Manufacturing > OTC > News
Actavis introduces generic version of AstraZeneca's Pulmicort Respules
By PBR Staff Writer
Irish specialty pharmaceutical firm Actavis has launched its generic version of AstraZeneca's Pulmicort Respules (budesonide inhalation suspension) 0.25 and 0.5mg vials.
Production & Manufacturing > OTC > News
Moberg Pharma introduces Kerasal Complete Care in US
By PBR Staff Writer
Swedish pharmaceutical firm Moberg Pharma has launched its new line extension, Kerasal Complete Care, a new foot care product, in the US.
Production & Manufacturing > OTC > News
USPTO issues patent relating to Moberg Pharma's MOB-015 to treat onychomycosis
By PBR Staff Writer
The US Patent and Trademark Office (USPTO) has issued US patent relating to Moberg Pharma's topical treatment MOB-015 for the treatment onychomycosis and this patent is expected to be in effect until 2032.
Production & Manufacturing > OTC > News
Moberg Pharma, Berlin-Chemie extend distribution deal for Emtrix
By PBR Staff Writer
Swedish pharmaceutical firm Moberg Pharma has extended its distribution agreement with Berlin-Chemie, a German subsidiary of the MENARINI Group, granting exclusive rights to market and sell Emtrix in Russia and Ukraine.
Production & Manufacturing > OTC > News
Actavis to divest US rights of Doryx to Mayne Pharma for $50m
By PBR Staff Writer
Irish specialty pharmaceutical firm Actavis has entered into an agreement to divest the US rights of Doryx brand acne treatment and related assets to Mayne Pharma for about $50m.
Production & Manufacturing > OTC > News
BPI Sports adopts ChromaDex quality verification seal program
ChromaDex, an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that sports nutrition supplier BPI Sports has contracted with ChromaDex for third-party verification of BPI Sports' protein products.
Production & Manufacturing > OTC > News
Nutra Pharma announces distribution of OTC pain drug Nyloxin to India
Nutra Pharma, a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced that they have shipped their initial test orders of their Over-the-Counter pain drug, Nyloxin, to S.Zhaveri Pharmakem for distribution throughout India.
Production & Manufacturing > OTC > News
FDA accepts Actavis' sNDA to expand Teflaro labeling for ABSSSI with concurrent bacteremia
By PBR Staff Writer
The US Food and Drug Administration (FDA) has accepted for filing Irish pharmaceutical firm Actavis' supplemental new drug application (sNDA) to expand the label for Teflaro (ceftaroline-fosamil) to treat cases of concurrent bacteremia in patients with acute bacterial skin and skin structure infections (ABSSSIs).
Production & Manufacturing > OTC > News
Inergetics completes final launch preparations for new CBD-Based pain relief supplement
Inergetics, a world-class developer of nutritional and consumer products, announced that it is completing the final development phase for its new Cannabidiol (CBD)-based pain relief product.
Production & Manufacturing > OTC > News
View all OTC news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250